Fang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fang Liu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Linyan Cao
Department of Gynecology The Second Affiliated Hospital of Jiaxing University Jiaxing China
1 shared publicationXinyi Xia
Department of Gynecology The Second Affiliated Hospital of Jiaxing University Jiaxing China
1 shared publicationYanhua Ji
Department of Gynecology The Fourth People's Hospital of Tongxiang Jiaxing China
1 shared publicationYufang Zhang
Department of Gynecology The Second Affiliated Hospital of Jiaxing University Jiaxing China
1 shared publication
Latest Publications
- Open Access
- 2 July 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (8) , e25470
LncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
Background: Serous ovarian carcinoma (SOC) is a common malignant tumor in female reproductive system. Long noncoding RNA (lncRNA) LIFR‐AS1 is a tumor suppressor gene in colorectal cancer, but its effect and underlying mechanism in SOC are still unclear. Therefore, this study focuses on unveiling the regulatory mechanism of LIFR‐AS1 in SOC.Methods: The relationship between LIFR‐AS1 expression and prognosis of SOC patients was analyzed by TCGA database and Starbase, and then, the LIFR‐AS1 expression in SOC tissues and cells was detected by quantitative real‐time PCR (qRT‐PCR) and in situ hybridization (ISH). Besides, the relationship between LIFR‐AS1 and clinical characteristics was analyzed. Also, the effects of LIFR‐AS1 on the biological behaviors of SOC cells were measured by Cell Counting Kit‐8, colony formation, and wound‐healing and Transwell assays, respectively. Western blot and qRT‐PCR were employed to determine the protein expressions of genes related to proliferation (PCNA), apoptosis (cleaved caspase‐3), epithelial‐mesenchymal transition (E‐cadherin, N‐cadherin, and Snail).Results: LIFR‐AS1 was lowly expressed in SOC, which was correlated with the poor prognosis of SOC patients. Low expression of LIFR‐AS1 in SOC was associated with the tumor size, clinical stage, lymph node metastasis, and distant metastasis. LIFR‐AS1 overexpression promoted the expressions of cleaved caspase‐3 and E‐cadherin while suppressing the malignant behaviors (proliferation, migration, and invasion) of SOC cells, the expressions of PCNA, N‐cadherin, and Snail. Besides, silencing LIFR‐AS1 exerted the effects opposite to overexpressed LIFR‐AS1.Conclusion: LIFR‐AS1 overexpression inhibits biological behaviors of SOC cells, which may be a new therapeutic method.
- 2 July 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (8) , e25470
Open AccessLncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
Background: Serous ovarian carcinoma (SOC) is a common malignant tumor in female reproductive system. Long noncoding RNA (lncRNA) LIFR‐AS1 is a tumor suppressor gene in colorectal cancer, but its effect and underlying mechanism in SOC are still unclear. Therefore, this study focuses on unveiling the regulatory mechanism of LIFR‐AS1 in SOC.Methods: The relationship between LIFR‐AS1 expression and prognosis of SOC patients was analyzed by TCGA database and Starbase, and then, the LIFR‐AS1 expression in SOC tissues and cells was detected by quantitative real‐time PCR (qRT‐PCR) and in situ hybridization (ISH). Besides, the relationship between LIFR‐AS1 and clinical characteristics was analyzed. Also, the effects of LIFR‐AS1 on the biological behaviors of SOC cells were measured by Cell Counting Kit‐8, colony formation, and wound‐healing and Transwell assays, respectively. Western blot and qRT‐PCR were employed to determine the protein expressions of genes related to proliferation (PCNA), apoptosis (cleaved caspase‐3), epithelial‐mesenchymal transition (E‐cadherin, N‐cadherin, and Snail).Results: LIFR‐AS1 was lowly expressed in SOC, which was correlated with the poor prognosis of SOC patients. Low expression of LIFR‐AS1 in SOC was associated with the tumor size, clinical stage, lymph node metastasis, and distant metastasis. LIFR‐AS1 overexpression promoted the expressions of cleaved caspase‐3 and E‐cadherin while suppressing the malignant behaviors (proliferation, migration, and invasion) of SOC cells, the expressions of PCNA, N‐cadherin, and Snail. Besides, silencing LIFR‐AS1 exerted the effects opposite to overexpressed LIFR‐AS1.Conclusion: LIFR‐AS1 overexpression inhibits biological behaviors of SOC cells, which may be a new therapeutic method.